Orange Organic Fruit Spread
MRT 176 Panel Triggers Identified
Clinical Product Assessment
MRT Safety Assessment
This product contains three MRT-tested substances: Orange, Cane Sugar, and Lemon. Under the LEAP protocol, the presence of three or more tested triggers classifies the item as High Risk, requiring direct practitioner guidance to determine individual suitability based on specific reactivity scores.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 3
- Safe Ingredients: 1
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| oranges | Orange | Direct Match |
| sugar | Cane Sugar | Direct Match |
| lemon juice | Lemon | Direct Match |
LEAP Protocol Guidance
With 3 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist.
UPC Code: 0681170317503
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Orange is an MRT-tested citrus fruit. Found in juice, marmalade, candied peel, and as natural orange flavoring. Cross-reactivity with other citrus fruits is not assumed on the MRT panel.
Cane sugar sensitivity is specific to sugarcane-derived sweeteners and is distinct from glucose intolerance. Look for it in ingredient lists as sucrose, cane juice, or turbinado sugar.
Lemon is tested as a standalone citrus substance on the MRT panel. It appears in beverages, dressings, marinades, and as a flavoring agent. Distinct from citric acid sensitivity.
What This Means For Your Diet
With 3 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 3 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners